left-caret
news

News

Paul Hastings advises Keensight Capital on the LBO of Unither Pharmaceuticals

October 28, 2022

Paris – Paul Hastings (Europe) LLP advised Keensight Capital on the LBO of Unither Pharmaceuticals, structured, alongside the management team by a consortium composed of GIC, Keensight Capital, IK Partners and Parquest. The transaction is subject to approval by various regulatory authorities.

The Paul Hastings team was led by partners Olivier Deren and Sébastien Crepy, and included associate Vincent Nacinovic on the corporate and contractual aspects, and partners Olivier Vermeulen and Marc Zerah on the financing aspects.

More details about the transaction can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment and real estate, Paul Hastings is a premier law firm providing superior intellectual capital and execution globally to the world’s leading investment banks, asset managers and corporations.

 

Practice Areas


SIGN UP FOR NEWS INSIGHTS

MEDIA CONTACTS

Submission Requests
Corporate, Litigation, Real Estate, and Tax
Scott Wasserman
Intellectual Property, Life Sciences, and Employment
Becca Hatton
Europe
Rostrum
Paris
Katy Foster

Get In Touch With Us

Contact Us